CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia

Published:2018-10-16 Issue:2 Volume:96 Page:143-148
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Mora Alba¹²³⁴,Bosch Rosa¹²⁴,Cuellar Carolina¹²⁴,Vicente Eva Puy¹²,Blanco Laura⁵,Martino Rodrigo²,Ubeda José M.⁵,Sierra Jorge¹²⁴,Moreno Carol¹²³⁴,Nomdedeu Josep⁵

Affiliation:

1. Laboratory of Oncology/Hematology and TransplantationInstitute of Biomedical Research Barcelona Spain

2. Department of Hematology, Hospital de la Santa Creu i Sant PauAutonomous University of Barcelona Spain

3. Department of MedicineAutonomous University of Barcelona Barcelona Spain

4. Biomedical Research Institute (IIB‐Sant Pau) and José Carreras Leukemia Research Institute

5. Laboratory of HematologyHospital de la Santa Creu i Sant Pau Barcelona Spain

Funder

Fundación Científica Asociación Española Contra el Cáncer

Instituto de Salud Carlos III

National Cancer Institute

Fundación Cellex

Ministerio de Ciencia e Innovación

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21722

Reference36 articles.

1. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

3. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment

4. Chronic lymphocytic leukaemia

5. Expression of human B cell‐associated antigens on leukemias and lymphomas: a model of human B cell differentiation;Anderson KC;Blood,1984

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study;Indian Journal of Hematology and Blood Transfusion;2023-11-30

2. Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany;Clinical and Experimental Medicine;2023-11-18

3. Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency and Chronic Lymphocytic Leukemia;Cancers;2023-10-28

4. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders;British Journal of Biomedical Science;2023-09-26

5. Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients;Annales de Biologie Clinique;2023-08